CD274 and cancer: A key mechanism by which tumors evade immune surveillance is through the upregulation of immune checkpoints such as programmed death-1 (PD-1) and programmed death ligand-1 (PD-L1), which inhibit T-cell activity and allow cancer cells to thrive unchecked (Wei et al., 2019).